Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

Levothyroxine (LT4) therapy has a long history, a well-defined pharmacological profile and a favourable safety record in the alleviation of hypothyroidism. However, questions remain in defining the threshold for the requirement of treatment in patients with subclinical hypothyroidism, assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoermann, Rudolf, Midgley, John E M, Larisch, Rolf, Dietrich, Johannes W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726361/
https://www.ncbi.nlm.nih.gov/pubmed/31516533
http://dx.doi.org/10.7573/dic.212597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726361/
https://www.ncbi.nlm.nih.gov/pubmed/31516533
http://dx.doi.org/10.7573/dic.212597

Ejemplares similares